Thomas Michael Farrell

US Patent:

6902609, Jun 7, 2005

Filed:

Feb 13, 2004

Appl. No.:

10/778600

Inventors:

Rita M. Steffenino - Green Lane PA, US
Franklin J. Gulian - Schwenksville PA, US
Irvin M. Lash - Pennsburg PA, US
Thomas P. Farrell - Warrington PA, US
Charles D. Fields - West Mailing, GB

Assignee:

BPSI Holdings, Inc. - Wilmington DE

International Classification:

C09D005/36
C09D101/00
C09D101/26
C09D101/28
C09D105/00

US Classification:

1061628, 1061629, 424476, 424480, 427 223, 427415, 426103, 426302, 426303, 426304

Abstract:

The present invention is directed to film coating systems for use on oral dosage forms such as compressed tablets and orally-ingestible substrates which have improved pearlescent qualities. The film coating systems can be applied either directly to a substrate or after the substrate has been coated with a subcoat. In preferred aspects, the pearlescent film coating is prepared as a dry powder mixture containing a cellulosic polymer, a detackifier, a gloss enhancer, and a pearlescent pigment. Film coating compositions containing an aqueous suspension of the powder mixtures, methods of applying the coatings to substrates and the coated substrates are also disclosed.

US Patent:

8388983, Mar 5, 2013

Filed:

Apr 28, 2010

Appl. No.:

12/769197

Inventors:

Thomas P. Farrell - Warrington PA, US
Jason Teckoe - Lansdale PA, US
Barry Friend - Dartford, GB
Scott Gulian - Lansdale PA, US

Assignee:

BPSI Holdings, LLC - Wilmington DE

International Classification:

A61K 47/32
A61K 9/00
B05D 7/00
C08K 5/41

US Classification:

424400, 427 214, 524156, 5147726

Abstract:

The present invention is directed to film coating compositions for use on oral dosage forms such as compressed tablets and other orally-ingestible substrates which contain a fine particle size detackifier. The film coating compositions can be applied either directly to a substrate or after the substrate has been coated with a subcoat. In preferred aspects, the polymer is either polyvinyl alcohol or a copolymer of polyvinyl alcohol. Aqueous suspensions comprising the inventive film coating compositions, methods of applying the coatings to substrates and the coated substrates themselves are also disclosed.

US Patent:

8647645, Feb 11, 2014

Filed:

Apr 28, 2010

Appl. No.:

12/769188

Inventors:

Thomas P. Farrell - Warrington PA, US
Jason Teckoe - Lansdale PA, US

Assignee:

BPSI Holdings, LLC - Wilmington DE

International Classification:

A61K 47/10

US Classification:

424400, 424463, 424474, 424475, 424482, 424490, 424497

Abstract:

The present invention is directed to immediate release film coating systems for use on oral dosage forms such as compressed tablets and other orally-ingestible substrates which have improved moisture barrier properties. The film coating systems can be applied either directly to a substrate or after the substrate has been coated with a subcoat. In preferred aspects, the moisture barrier film coating is prepared as a dry powder mixture containing polyvinyl alcohol, a polymer with pH dependent solubility, a plasticizer, a glidant, and, optionally, a detackifier, an alkalizing agent and a pigment. Film coating compositions containing an aqueous suspension of the powder mixtures, methods of applying the coatings to substrates and the coated substrates are also disclosed.

US Patent:

20060134216, Jun 22, 2006

Filed:

Dec 16, 2005

Appl. No.:

11/305900

Inventors:

Thomas Farrell - Warrington PA, US
Kurt Fegely - Gilbertsville PA, US
George Reyes - Perkiomenville PA, US
Budhi Simon - Harleysville PA, US
Cara Young - Blue Bell PA, US

International Classification:

A61K 9/24

US Classification:

424472000

Abstract:

Dry, enteric, film-coating compositions and aqueous dispersions containing the same are disclosed. When applied to orally-ingestible substrates such as oral solid dosage forms, the film coatings are capable of preventing the substrates from disintegrating in media with pH values from about 1 to about 4.5 or higher values. One preferred film-coating composition contains a micronized intermediate comprised of an acrylic resin and talc. Advantageously and surprisingly, the preferred film-coating composition does not contain an alkalizing agent.

US Patent:

20060251724, Nov 9, 2006

Filed:

May 6, 2004

Appl. No.:

10/554677

Inventors:

Thomas Farrell - Warrington PA, US
Kurt Fegely - Limerick PA, US
Christopher Young - Austin TX, US
Michael Crowley - Austin TX, US
James McGinity - Austin TX, US

International Classification:

A61K 9/14
C08L 33/04

US Classification:

424487000, 525222000

Abstract:

Thermoformed or hot melt extruded pharmaceutical compositions containing an active pharmaceutical ingredient, acrylic enteric polymer and plasticizer are disclosed. Methods of making the same as well as various pharmaceutical dosage forms are also disclosed. In preferred aspects, a thermoformable mixture is in a powder form and includes an active ingredient, plasticizer, acrylic polymer and optional excipients which enhance the performance of the extrudate after being incorporated into a dosage form.

US Patent:

51779994, Jan 12, 1993

Filed:

Feb 10, 1992

Appl. No.:

7/833814

Inventors:

Edward L. Tobolski - Owego NY
Thomas P. Farrell - Endicott NY
Giacinto Vallone - Endicott NY

Assignee:

Wilson Instruments Inc. - Binghamton NY

International Classification:

G01N 342

US Classification:

73 82

Abstract:

A microhardness tester comprises a turret capable of holding a plurality of load rod assemblies such that, when the optical objective elements mounted on the turret have been properly aligned with respect to the indenter of one load rod assembly desired to impinge upon a specimen to test for microhardness and it subsequently becomes desirable to use a second load rod assembly to change scales for the testing, it is only necessary to properly align the indenter of the second load rod assembly and not the objective elements with the test specimen. The load rod assembly of the microhardness tester free falls in its testing mode, and a spring is provided for retaining the load rod in a home position spaced away from the test specimen. Thus, the load weights applied to the load rod as carried to the test specimen are not affected by spring load tolerances such that weight calibration can be completed during the weight manufacturing process. Likewise, the weight stack constituting the additional load is guided on a vertical shaft impinging on the load rod so as to provide for actual weights without the need for calibrating spring gradients.

US Patent:

20220325096, Oct 13, 2022

Filed:

Aug 21, 2020

Appl. No.:

17/634986

Inventors:

- Doylestown PA, US
James Walsh - Doylestown PA, US
William Miles - Collegeville PA, US
Thomas Farrell - Doylestown PA, US
Julie Cuddigan - Allentown PA, US
Javiera Rubilar - Ambler PA, US
Kenneth Myers - Schwenksville PA, US
Andrew Sandt - Eagleville PA, US
Mark Adams - Hellertown PA, US
Youcef Lariane - Lansdale PA, US

International Classification:

C08L 67/02

Abstract:

The present disclosure generally relates to opaque, non-pearlescent polyester articles having at least one layer formed from a polymer blend composition that includes a polyester matrix polymer, an incompatible polymer, and little to no mineral filler, and methods of manufacturing the opaque, non-pearlescent polyester articles.

US Patent:

20190244697, Aug 8, 2019

Filed:

Feb 4, 2019

Appl. No.:

16/267109

Inventors:

Thomas Farrell - Doylestown PA, US

International Classification:

G16H 20/10
G16H 10/60

Abstract:

The disclosure according to some exemplary embodiments relates generally to an infrastructure for electronic records (e.g., electronic medical records (EMRs), electronic health records (EHRs), and personal health records (PHRs)). The infrastructure allows the use, for example, of the electronic records and other information sources to determine drug and other treatment prices that may differ from listed prices based on various factors, such as approved indication treated, the organization and/or individual responsible for payment, whether and what other drug or drugs are used as part of the treatment regimen, a diagnosis and treatment plan, and responses to treatment, among other factors. Advantageously, in some embodiments, systems and methods using the infrastructure allows patients to receive lower drug and treatment prices tailored to the patients' needs and can increase patients' access to drugs and other treatments.